CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

International Stem Cell CORP

ISCO
$1M
Micro Cap
NASDAQPharmaceutical Preparations🇺🇸North AmericaSAN DIEGO

Drugs in Pipeline

12

Phase 3 Programs

3

Upcoming Catalysts

3

Next Catalyst

Oct 18, 2026

10w

Market Overview

Stock performance and key metrics

ISCO News
Catalyst Timeline

3 upcoming, 0 past

Market-Implied Move
Regulatory Approvals

Frequently asked questions

What is in International Stem Cell CORP's drug pipeline?

CatalystAlert tracks 12 drug candidates in International Stem Cell CORP's (ISCO) pipeline across Phase 3, Phase 2. Its lead program is Permethrin Cream, 5% (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is International Stem Cell CORP's next FDA catalyst?

International Stem Cell CORP's (ISCO) next tracked catalyst is a Conference expected October 18, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track ISCO biotech catalysts?

Add ISCO to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow International Stem Cell CORP's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply